Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Joo Cho

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Retina (Philadelphia, Pa.)|February 27, 2026
Comparison of Initial Loading Injection Outcomes Between Aflibercept 8 mg and Faricimab in Neovascular Age-Related Macular DegenerationHee Yong Han, Sang Min Park, Chul Gu Kim, et al.
Retina (Philadelphia, Pa.)|February 13, 2013
Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyesJi Sun Baek, Han Joo Cho, Sung Won Cho, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 28, 2023
Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal VasculopathyHan Joo Cho, Kyoung Hae Kang, Wontae Yoon, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 13, 2021
Nonexudative morphologic changes of neovascularization on optical coherence tomography angiography as predictive factors for exudative recurrence in age-related macular degenerationHan Joo Cho, Jaemin Kim, Seung Kwan Nah, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 27, 2019
Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid NeovasculopathyHan Joo Cho, Seong Heon Jung, Suyeon Cho, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 21, 2021
Assessing the long-term evolution of type 3 neovascularization in age-related macular degeneration using optical coherence tomography angiographyHan Joo Cho, Soo Hyun Lim, Jaemin Kim, et al.
Seminars in Ophthalmology|May 28, 2019
Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography AnalysisJae Min Kim, Han Joo Cho, Yeji Kim, et al.
Scientific Reports|December 9, 2021
Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularizationWontae Yoon, Jihyun Yoon, Seung Kwan Na, et al.
Retina (Philadelphia, Pa.)|May 17, 2019
CHANGES IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND DISEASE ACTIVITY IN TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENTJae Wook Han, Han Joo Cho, Dong Hyun Kang, et al.
Retina (Philadelphia, Pa.)|March 30, 2023
SUBRETINAL FLUID ASSOCIATED WITH DRUSENOID PIGMENT EPITHELIAL DETACHMENTHan Joo Cho, Young Joon Jeon, Wontae Yoon, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Retina (Philadelphia, Pa.)|February 27, 2026
Comparison of Initial Loading Injection Outcomes Between Aflibercept 8 mg and Faricimab in Neovascular Age-Related Macular DegenerationHee Yong Han, Sang Min Park, Chul Gu Kim, et al.
Retina (Philadelphia, Pa.)|February 13, 2013
Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyesJi Sun Baek, Han Joo Cho, Sung Won Cho, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 28, 2023
Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal VasculopathyHan Joo Cho, Kyoung Hae Kang, Wontae Yoon, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 13, 2021
Nonexudative morphologic changes of neovascularization on optical coherence tomography angiography as predictive factors for exudative recurrence in age-related macular degenerationHan Joo Cho, Jaemin Kim, Seung Kwan Nah, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 27, 2019
Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid NeovasculopathyHan Joo Cho, Seong Heon Jung, Suyeon Cho, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 21, 2021
Assessing the long-term evolution of type 3 neovascularization in age-related macular degeneration using optical coherence tomography angiographyHan Joo Cho, Soo Hyun Lim, Jaemin Kim, et al.
Seminars in Ophthalmology|May 28, 2019
Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography AnalysisJae Min Kim, Han Joo Cho, Yeji Kim, et al.
Scientific Reports|December 9, 2021
Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularizationWontae Yoon, Jihyun Yoon, Seung Kwan Na, et al.
Retina (Philadelphia, Pa.)|May 17, 2019
CHANGES IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND DISEASE ACTIVITY IN TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENTJae Wook Han, Han Joo Cho, Dong Hyun Kang, et al.
Retina (Philadelphia, Pa.)|March 30, 2023
SUBRETINAL FLUID ASSOCIATED WITH DRUSENOID PIGMENT EPITHELIAL DETACHMENTHan Joo Cho, Young Joon Jeon, Wontae Yoon, et al.
Pageof 7